Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial

• Main Authors: Olivia Oxlade, PhD (Author), Andrea Benedetti, PhD (Author), Mênonli Adjobimey, MD (Author), Hannah Alsdurf, PhD (Author), Severin Anagonou, ProfPhD (Author), Victoria J Cook, MD (Author), Dina Fisher, MD (Author), Greg J Fox, PhD (Author), Federica Fregonese, MD (Author), Panji Hadisoemarto, MD (Author), Philip C Hill, ProfMD (Author), James Johnston, MD (Author), Faiz Ahmad Khan, MD (Author), Richard Long, MD (Author), Nhung V Nguyen, MD (Author), Thu Anh Nguyen, PhD (Author), Joseph Obeng, MD (Author), Rovina Ruslami, ProfPhD (Author), Kevin Schwartzman, ProfMD (Author), Anete Trajman, ProfMD (Author), Chantal Valiquette (Author), Dick Menzies, ProfMD (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Reaching the UN General Assembly High-Level Meeting on Tuberculosis target of providing tuberculosis preventive treatment to at least 30 million people by 2022, including 4 million children under the age of 5 years and 20 million other household contacts, will require major effo...